Name: Moderna公司稱其疫苗的有效性為94.5%。 (Moderna says its vaccine is 94.5% effective)
Uploaded: 2020-11-16T18:45:16.000Z
Duration: 1 min 41 s

fresh hopes for an effective vaccine on Monday.

Madonna says it's experimental Shot is 94.5% effective in preventing covert 19 That's based on interim data from a late stage clinical trial.

麥當娜說它是實驗性的Shot在預防隱蔽19方面的有效性為94.5％這是基於後期臨床試驗的中期數據。

關係子句

It makes it the second U S company to report results that far exceed expectations.

這使其成為第二家公佈業績遠超預期的美國公司。

Together with the Pfizer vaccine on depending more safety data and regulatory review, the U.

與輝瑞疫苗一起取決於更多的安全數據和監管審查，美國。

S could have two vaccines authorized for emergency use by December.

S可在12月前準許兩種疫苗的緊急使用。

A key advantage off Madonna's vaccine is that it does not need ultra cold storage like Pfizer's, making it easier to distribute.

麥當勞疫苗的一個關鍵優勢是，它不像輝瑞那樣需要超低溫儲存，使其更容易配送。

Production of the Madonna shots will partially be carried out by Swiss biotechnology firm Lonza at plants in the US and Switzerland.

麥當娜針劑的生產將部分由瑞士生物技術公司Lonza在美國和瑞士的工廠進行。

The news sent Moderna shares up around 17%.

這一消息讓摩德納股價上漲了17%左右。

Also on Monday, Russia said it expects to produce primarily freeze dried Sputnik V Corona virus vaccine doses by the spring that would eliminate the need for transport at ultra low temperatures.

週一，俄羅斯還表示，預計到春季將主要生產冷凍乾燥的斯普特尼克五型電暈病毒疫苗劑型，這樣就不需要在超低溫下運輸。

Russia has an ambitious plan to inoculate its population, but vaccine developers globally are scrambling to work out how to ship and store their vials, some of which must be kept in specialized freezes at extremely low temperatures.

俄羅斯有一個雄心勃勃的計劃，為其人口接種疫苗，但全球的疫苗開發商正在爭分奪秒地研究如何運輸和儲存他們的小瓶，其中一些必須在極低的溫度下保存在專門的冷凍室。

The logistical challenge was brought into sharp focus after promising interim trial data for the vaccine developed by biotech and Pfizer.

在生物技術公司和輝瑞公司開發的疫苗有希望的中期試驗數據之後，後勤方面的挑戰被凸顯出來。

It's being considered a major breakthrough in the race to curb the pandemic, but it needs to be shipped and stored at minus 70 degrees Celsius, equivalent to an Antarctic winter that poses a challenge for even the most sophisticated hospitals.

它被認為是遏制流行病競賽的重大突破，但它需要在零下70攝氏度的溫度下運輸和儲存，相當於南極的冬天，這對最先進的醫院來說也是一個挑戰。

 For the moment, it also puts it out of reach for many poorer countries. 

目前，這也讓很多窮國望塵莫及。